<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33414684</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>C1q/TNF-Related Protein 9 Inhibits Coxsackievirus B3-Induced Injury in Cardiomyocytes through NF-<i>&#x3ba;</i>B and TGF-<i>&#x3b2;</i>1/Smad2/3 by Modulating THBS1.</ArticleTitle><Pagination><StartPage>2540687</StartPage><MedlinePgn>2540687</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2540687</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/2540687</ELocationID><Abstract><AbstractText>C1q/TNF-related protein 9 (CTRP9) is implicated in diverse cardiovascular diseases, but its role in viral myocarditis (VMC) is not well explored. This study is aimed at investigating the role and potential mechanism of CTRP9 in VMC. Herein, we found that the peripheral blood collected from children with VMC had lower CTRP9 levels than that from children who had recovered from VMC. H9c2 cardiomyocytes treated with coxsackievirus B3 (CVB3) were applied to establish a VMC model <i>in vitro</i>, and the expression of CTRP9 was significantly decreased in CVB3-induced H9c2 cells. The overexpression of CTRP9 attenuated CVB3-induced apoptosis, inflammation, and fibrosis reactions in H9c2 cells by promoting cell proliferation, reducing the cell apoptosis rate, and inhibiting inflammatory cytokine levels and fibrosis-related gene expression. Moreover, we found that thrombospondin 1 (THBS1) levels were increased in children with VMC, and CTRP9 negatively regulated THBS1 expression by interacting with THBS1. The downregulation of THBS1 inhibited CVB3-induced apoptosis, inflammation, and fibrosis in H9c2 cells. In addition, our mechanistic investigation indicated that the overexpression of THBS1 impaired the inhibitory effect of CTRP9 on CVB3-induced H9c2 cells. The results further revealed that the CVB3-induced NF-<i>&#x3ba;</i>B and TGF-<i>&#x3b2;</i>1/Smad2/3 signaling pathways of H9c2 cells were blocked by CTRP9 yet activated by THBS1. In conclusion, CTRP9 protected H9c2 cells from CVB3-induced injury via the NF-<i>&#x3ba;</i>B and TGF-<i>&#x3b2;</i>1/Smad2/3 signaling pathways by modulating THBS1.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Kebei Liu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kebei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Xi'an Children's Hospital, Xi'an, Shaanxi 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Xi'an Children's Hospital, Xi'an, Shaanxi 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xinru</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medical Ultrasound Center, The Northwest Women's and Children's Hospital, Xi'an, Shaanxi 710003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-8043-3751</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Xi'an Children's Hospital, Xi'an, Shaanxi 710003, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052002">NF-kappa B p50 Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489548">NFKB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497782">SMAD2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497790">SMAD3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051899">Smad2 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051900">Smad3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508960">TGFB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019700">Thrombospondin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000611726">thrombospondin-1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>80295-33-6</RegistryNumber><NameOfSubstance UI="D015922">Complement C1q</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015922" MajorTopicYN="N">Complement C1q</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052002" MajorTopicYN="N">NF-kappa B p50 Subunit</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051899" MajorTopicYN="N">Smad2 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051900" MajorTopicYN="N">Smad3 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019700" MajorTopicYN="N">Thrombospondin 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33414684</ArticleId><ArticleId IdType="pmc">PMC7769632</ArticleId><ArticleId IdType="doi">10.1155/2020/2540687</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moritz B. P., Frauke G., Karin K., et al. Cardiac function remains impaired despite reversible cardiac remodeling after acute experimental viral myocarditis. Clinical &amp; Developmental Immunology. 2017;2017, article 6590609:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5352897</ArticleId><ArticleId IdType="pubmed">28352641</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Gao X., Lin J., et al. MicroRNA-20b suppresses the expression of ZFP-148 in viral myocarditis. Molecular and Cellular Biochemistry. 2017;429(1-2):199&#x2013;210. doi: 10.1007/s11010-017-2947-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-017-2947-7</ArticleId><ArticleId IdType="pubmed">28247213</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang A., Xuefei L., Ge L., Haitao Y. Interleukin-37 ameliorates coxsackievirus B3-induced viral myocarditis by modulating the Th17/regulatory T cell immune response. Journal of Cardiovascular Pharmacology. 2017;69:305&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">28207428</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihui G., Zhen Z., Yang C., Yumei L. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization. Experimental Cell Research. 2018;366:41&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">29524390</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G., Zhang H. M., Qiu Y., Ye X., Yang D. Cleavage of desmosomal cadherins promotes &#x3b3;-catenin degradation and benefits Wnt signaling in coxsackievirus B3-induced destruction of cardiomyocytes. Frontiers in Microbiology. 2020;11:p. 767. doi: 10.3389/fmicb.2020.00767.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00767</ArticleId><ArticleId IdType="pmc">PMC7225294</ArticleId><ArticleId IdType="pubmed">32457708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Chuang L., Ping L. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells. Virology Journal. 2015;12(1):189&#x2013;189. doi: 10.1186/s12985-015-0418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0418-x</ArticleId><ArticleId IdType="pmc">PMC4650905</ArticleId><ArticleId IdType="pubmed">26578236</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidong L., Mao C., Xu L., et al. Morroniside alleviates coxsackievirus B3-induced myocardial damage apoptosis via restraining NLRP3 inflammasome activation. RSC Advances. 2019;9:1222&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9059572</ArticleId><ArticleId IdType="pubmed">35518014</ArticleId></ArticleIdList></Reference><Reference><Citation>Tianlong L., Mingjie Z., Haiyan N., et al. Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-&#x3ba;B p65 signal pathway and protects mice from CVB3-induced virus myocarditis. International Journal of Biological Macromolecules. 2018;126</Citation><ArticleIdList><ArticleId IdType="pubmed">30586589</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan R., Ramail S., Alessandra D., et al. Simvastatin reduces TGF-&#x3b2;1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: role of protein phosphatase activation. International Journal of Cardiology. 2018;270:228&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146406</ArticleId><ArticleId IdType="pubmed">30220377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuowang G., Youming C., Wang B., et al. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-&#x3b2;1/Smad2/3 pathway. Journal of Molecular and Cellular Cardiology. 2020;139:164&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">31958465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X. H., Fu J., Sun D. Q. Halofuginone alleviates acute viral myocarditis in suckling BALB/c mice by inhibiting TGF-&#x3b2;1. Biochemical and Biophysical Research Communications. 2016;473(2):558&#x2013;564. doi: 10.1016/j.bbrc.2016.03.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.03.118</ArticleId><ArticleId IdType="pubmed">27021682</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Xie Y., Shen E., et al. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-&#x3b2;1 signaling in coxsackievirus B3-induced cardiomyopathy. European Journal of Pharmacology. 2011;658(2-3):168&#x2013;174. doi: 10.1016/j.ejphar.2011.02.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.02.040</ArticleId><ArticleId IdType="pubmed">21371462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Yu J., Sun H., et al. Effects of ubiquitin-proteasome inhibitor on the expression levels of TNF-&#x3b1; and TGF-&#x3b2;1 in mice with viral myocarditis. Experimental and Therapeutic Medicine. 2019;18(4):2799&#x2013;2804. doi: 10.3892/etm.2019.7895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7895</ArticleId><ArticleId IdType="pmc">PMC6755415</ArticleId><ArticleId IdType="pubmed">31555373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L., Gao Y. Effect of lipid factor CTRP9 on myocardial remodeling induced by isoproterenol in mice. Zhonghua Yi Xue Za Zhi. 2018;98:3025&#x2013;3031.</Citation><ArticleIdList><ArticleId IdType="pubmed">30392262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dajun Z., Pan F., Yang S., et al. Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Cell Death and Disease. 2018;9:p. 723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6010444</ArticleId><ArticleId IdType="pubmed">29925877</ArticleId></ArticleIdList></Reference><Reference><Citation>Nariman M., Reza F., Solaleh E., et al. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. PLoS One. 2018;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5790264</ArticleId><ArticleId IdType="pubmed">29381773</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahiro K., Koji O., Rei S., et al. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. Journal of Biological Chemistry. 2012;287:18965&#x2013;18973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3365930</ArticleId><ArticleId IdType="pubmed">22514273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui S., Yuexing Y., Ming W. X., Bond L. W., Liang M. X. Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNF&#x3b1;-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice. Basic Research in Cardiology. 2013;108:p. 315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6408949</ArticleId><ArticleId IdType="pubmed">23212557</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingyang X., Shuzhen L., Hengliang S., Xie Y., Wan D. Cardiology Department Of. Effects of overexpression of CTRP9 mediated by AAV9 on myocardial fibrosis in diabetic rats. Journal of Zhengzhou University. 2017;52:570&#x2013;574.</Citation></Reference><Reference><Citation>Takahiro K., Rei S., Koji O., et al. C1q/tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-dependent mechanism. Molecular and Cellular Biology. 2015;35:2173&#x2013;2185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4438248</ArticleId><ArticleId IdType="pubmed">25870106</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas Nicola M., Beck Laurence H., Catherine M., et al. Thrombospondin Type-1 domain-containing 7A in idiopathic membranous nephropathy. The New England Journal of Medicine. 2014;371(24):2277&#x2013;2287. doi: 10.1056/NEJMoa1409354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1409354</ArticleId><ArticleId IdType="pmc">PMC4278759</ArticleId><ArticleId IdType="pubmed">25394321</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts David D., Miller Thomas W., Rogers Natasha M., Mingyi Y., Isenberg Jeffrey S. The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biology. 2012;31(3):162&#x2013;169. doi: 10.1016/j.matbio.2012.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2012.01.005</ArticleId><ArticleId IdType="pmc">PMC3295899</ArticleId><ArticleId IdType="pubmed">22266027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingyun C., Prasadh R. D., Silverstein Roy L. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells. Blood. 2013;122:1822&#x2013;1832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765061</ArticleId><ArticleId IdType="pubmed">23896411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying X., Marcin D., Carlos G., et al. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension. 2011;58:902&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3199343</ArticleId><ArticleId IdType="pubmed">21947471</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Almen G. C., Wouter V., Rick V. L., et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell. 2011;10(5):769&#x2013;779. doi: 10.1111/j.1474-9726.2011.00714.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2011.00714.x</ArticleId><ArticleId IdType="pmc">PMC3193380</ArticleId><ArticleId IdType="pubmed">21501375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Xu L. Y., Lam K. S., Lu G., Cooper G. J., Xu A. Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin. Proteomics. 2006;6(13):3862&#x2013;3870. doi: 10.1002/pmic.200500840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200500840</ArticleId><ArticleId IdType="pubmed">16767790</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson B., Ali M., Grant S., et al. Thrombospondin-1 exacerbates acute liver failure and hepatic encephalopathy pathology in mice by activating transforming growth factor &#x3b2;1. The American Journal of Pathology. 2020;190(2):347&#x2013;357. doi: 10.1016/j.ajpath.2019.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2019.10.003</ArticleId><ArticleId IdType="pmc">PMC7013272</ArticleId><ArticleId IdType="pubmed">31734229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X., Wang Y., Wenjie D., et al. Thrombospondin-1 production regulates the inflammatory cytokine secretion in THP-1 cells through NF-&#x3ba;B signaling pathway. Inflammation. 2017;40:1606&#x2013;1621.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruicheng Z., Liangbao Z., Jufeng Z., Youming P. Complement-C1q TNF-related protein 3 alleviates mesangial cell activation and inflammatory response stimulated by secretory IgA. American Journal of Nephrology. 2016;43:460&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">27309491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B. K., Adya R., Chen J., et al. Metformin decreases angiogenesis via NF-&#x3ba;B and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovascular Research. 2009;83</Citation><ArticleIdList><ArticleId IdType="pubmed">19414528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Shuang C., Wang W. X., et al. Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by coxsackievirus B infection. Antiviral Research. 2019;166:1&#x2013;10. doi: 10.1016/j.antiviral.2019.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.03.007</ArticleId><ArticleId IdType="pubmed">30904424</ArticleId></ArticleIdList></Reference><Reference><Citation>Xingmei Q., Sidong X. Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis. Scientific Reports. 2017;7:p. 41485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5288654</ArticleId><ArticleId IdType="pubmed">28148910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinyu C., Yu S., Chunnan L., et al. Nox4-dependent ROS production is involved in CVB3-induced myocardial apoptosis. Biochemical and Biophysical Research Communications. 2018;503:1641&#x2013;1644.</Citation><ArticleIdList><ArticleId IdType="pubmed">30055798</ArticleId></ArticleIdList></Reference><Reference><Citation>Fangqiang S., Kong F., Hongqing Z., Yongqin Z., Ming L. Ulinastatin protects against CVB3-induced acute viral myocarditis through Nrf2 activation. Inflammation. 2018;41:803&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">29383542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Wei Y., Yuexing Y., et al. C1q/tumor necrosis factor&#x2013;related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation. 2013;128</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824619</ArticleId><ArticleId IdType="pubmed">24030394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingxin L., Lin Y., Wei L., et al. C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction. Journal of Cellular Physiology. 2019;234:18731&#x2013;18747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6618013</ArticleId><ArticleId IdType="pubmed">30953351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanxing B., Cheng L., Yang Y., et al. C1q/TNF-related protein 9 protects diabetic rat heart against ischemia reperfusion injury: role of endoplasmic reticulum stress. Oxidative Medicine and Cellular Longevity. 2016;2016:14.1902025</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5067328</ArticleId><ArticleId IdType="pubmed">27795806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Q., Bangying Z., Ya S., et al. Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis. eLife. 2020;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6992386</ArticleId><ArticleId IdType="pubmed">31934850</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna Smriti M., Jonathan G. The role of thrombospondin-1 in cardiovascular health and pathology. International Journal of Cardiology. 2013;168(2):692&#x2013;706. doi: 10.1016/j.ijcard.2013.04.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.04.139</ArticleId><ArticleId IdType="pubmed">23664438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopezdee Zenaida P., Kenneth P., Gutierrez Linda S. Thrombospondin-1: multiple paths to inflammation. Mediators of Inflammation. 2011;2011:10.296069</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3134184</ArticleId><ArticleId IdType="pubmed">21765615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhenjie L., Stephanie M., Jun R., et al. Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm. Circulation Research. 2015;117:p. 129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4490953</ArticleId><ArticleId IdType="pubmed">25940549</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor Jacques E., Mitra Raj S., Sutorik Michelle M., Mooney David J., Castle Valerie P., Polverini P. J. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. Journal of Vascular Research. 2000;37:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">10859480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan Z. H. A. N. G., Jing L. I. U., Tian-long L. I. U., et al. Astragalus triterpenoid saponins attenuated CVB3-induced cardiac fibrosis via suppressed TGF-&#x3b2;1/Smad2,p38MAPK signal pathway. Molecular Cardiology of China. 2018;18:2631&#x2013;2634.</Citation></Reference><Reference><Citation>Wen Y., Hailian B., Lixin L., et al. Knockout of immunoproteasome subunit &#x3b2;2i ameliorates cardiac fibrosis and inflammation in DOCA/salt hypertensive mice. Biochemical and Biophysical Research Communications. 2017;490:84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">28478040</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S., Xianqun M., Wang Z., Jiali L., Kuang H., Wang Q. Polysaccharide from Ephedra sinica Stapf inhibits inflammation expression by regulating factor-&#x3b2;1/Smad2 signaling. International Journal of Biological Macromolecules. 2018;106:947&#x2013;954. doi: 10.1016/j.ijbiomac.2017.08.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2017.08.096</ArticleId><ArticleId IdType="pubmed">28830773</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoomeh B., Farhad Z., Mehrdad H., Majid K., Mansooreh S. TGF- &#x3b2;1&#x2013;mediated apoptosis associated with SMAD-dependent mitochondrial Bcl-2 expression. Clinical Lymphoma, Myeloma &amp; Leukemia. 2012;12:138&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">22297256</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui S., Yong Z., Xiuping B., Shaohua L., Guohai S. Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats. Diagnostic Pathology. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4460645</ArticleId><ArticleId IdType="pubmed">25884585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Dan L., Jing O., et al. Leonurine alleviates LPS-induced myocarditis through suppressing the NF-&#x43a;B signaling pathway. Toxicology. 2019;422:1&#x2013;13. doi: 10.1016/j.tox.2019.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2019.04.011</ArticleId><ArticleId IdType="pubmed">31005592</ArticleId></ArticleIdList></Reference><Reference><Citation>Remels A. H. V., Derks Wouter J. A., Cilleropastor B., et al. NF-&#x3ba;B-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis. Biochimica et Biophysica Acta. 2018;1864:2579&#x2013;2589.</Citation><ArticleIdList><ArticleId IdType="pubmed">29730342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>